Salesforce’s Q2 FY27 performance revealed a 14% rise in contracted remaining performance obligation and 6% organic revenue growth, bolstered by a $2.53 EPS contribution from its Anthropic stake. This report highlights a strategic mix of operational growth and capital allocation success, marking a tentative turning point for B2B SaaS market sentiment.
- Contracted revenue grows 14%, outpacing recognized revenue.
- Organic subscription revenue rises 6.4% excluding acquisitions.
- EPS boost driven largely by Anthropic investment valuation.
Market signal
Salesforce’s 14% growth in contracted remaining performance obligation (cRPO) substantially outpaces its 11% top-line revenue increase, demonstrating strong new bookings momentum that sets the stage for future revenue acceleration. The 6.4% organic growth rate excluding recent acquisitions indicates underlying demand stability within core subscription products.
The 23% stock price rise following the earnings release reflects market optimism around Salesforce’s durable growth narrative and its strategic portfolio of investments, including its stake in Anthropic. This dynamic signals a possible easing of the prior B2B SaaS market downturn and renewed investor focus on book-to-bill ratios and contract visibility.
Operator impact
Operators should note that revenue segmentation reveals differing growth trajectories: core sales and service products excluding Slack grew slower than overall app growth, while Data 360 platforms led by acquisitions like Informatica contributed significantly but with some offsetting license revenue headwinds. This complexity requires nuanced sales and product strategies tailored to distinct revenue streams.
Capital allocation decisions are increasingly impactful: Salesforce’s aggressive stock buybacks amid elevated debt levels and a large contribution to earnings from investment valuation gains underscore a balancing act between operational reinvestment and shareholder returns. Operators will need to carefully assess the leverage and risk profiles of their own capital strategies in this context.
What to watch next
Future quarters will be critical to verify if Salesforce’s organic revenue reacceleration sustains beyond acquisition effects and if early recovery signs in marketing technologies can translate into more durable growth. Close attention to forward bookings and mix shifts between subscription and license revenues will provide important market signals.
Additionally, operators and buyers should monitor Salesforce’s ongoing portfolio management of strategic investments, including Anthropic, and how these may affect earnings volatility and capital deployment. The evolving balance sheet profile, including rising interest expenses linked to leverage, is another key factor shaping competitive positioning.